WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Randy Rasmussen Biography and Net Worth

CFO of Phreesia

As Chief Financial Officer, Randy Rasmussen oversees the company's budgeting, forecasting, monthly reporting, financial analysis and internal controls. Randy has 25 years of finance and accounting experience in software and technology companies.

Prior to joining Phreesia, Randy was Senior Vice President and Controller at Medidata Solutions where he managed global accounting operations, including SEC reporting and financial planning and analysis. Prior to Medidata, he spent over a decade in finance and accounting leadership roles with SAP. He earned his BBA in accounting and finance from the University of Colorado at Boulder. He is also a Certified Public Accountant.

What is Randy Rasmussen's net worth?: The estimated net worth of Randy Rasmussen is at least $3.66 million as of February 2nd, 2023. Mr. Rasmussen owns 145,594 shares of Phreesia stock worth more than $3,663,145 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Rasmussen may own. Learn More about Randy Rasmussen's net worth.
How do I contact Randy Rasmussen?: The corporate mailing address for Mr. Rasmussen and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Randy Rasmussen's contact information.
Has Randy Rasmussen been buying or selling shares of Phreesia?: Randy Rasmussen has not been actively trading shares of Phreesia over the course of the past ninety days. Most recently, Randy Rasmussen sold 4,765 shares of the business's stock in a transaction on Thursday, February 2nd. The shares were sold at an average price of $40.00, for a transaction totalling $190,600.00. Following the completion of the sale, the chief financial officer now directly owns 145,594 shares of the company's stock, valued at $5,823,760. Learn More on Randy Rasmussen's trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 62 times. They sold a total of 229,065 shares worth more than $5,314,510.63. The most recent insider tranaction occured on December, 18th when General Counsel Allison C Hoffman sold 3,495 shares worth more than $86,955.60. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 12/18/2024.

Randy Rasmussen Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/2/2023	Sell	4,765	$40.00	$190,600.00	145,594
12/12/2022	Sell	7,395	$31.77	$234,939.15	108,539
12/9/2022	Sell	9,934	$30.39	$301,894.26	115,934
1/19/2022	Sell	2,228	$32.66	$72,766.48

Randy Rasmussen Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $25.16

$23.18

$25.63

50 Day Range

MA: $20.81

$18.04

$25.66

2 Week Range

Now: $25.16

$17.07

$29.16

Volume

749,260 shs

Average Volume

452,361 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98